Kearney, K., Tomlinson, D., Smith, K., & Ajjan, R. (2017). Hypofibrinolysis in diabetes: A therapeutic target for the reduction of cardiovascular risk. Cardiovasc Diabetol.
Styl ChicagoKearney, Katherine, Darren Tomlinson, Kerrie Smith, a Ramzi Ajjan. "Hypofibrinolysis in Diabetes: A Therapeutic Target for the Reduction of Cardiovascular Risk." Cardiovasc Diabetol 2017.
Citace podle MLAKearney, Katherine, Darren Tomlinson, Kerrie Smith, a Ramzi Ajjan. "Hypofibrinolysis in Diabetes: A Therapeutic Target for the Reduction of Cardiovascular Risk." Cardiovasc Diabetol 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..